Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus. “Uncomplicated UTIs are…
#pivya #pivmecillinam #proteusmirabilis #peterkim #fda #uncomplicated #uti #clostridioides
Continue reading...